ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil

This study has been completed.
Study NCT00004755.   Last updated on June 23, 2005.   Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Leishmaniasis
2 Additional conditions recognized in this trial
Leishmaniasis, Cutaneous
3 More general conditions related to this trial
Mastigophora Infections
Parasitic Diseases
Protozoan Infections
Sarcomastigophora Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
4 Interventions listed in this trial
allopurinol
glucantime
5 Additional drug interventions recognized in this trial
Meglumine antimoniate
6 More general drug interventions related to this trial
Anti-Infective Agents
Antimetabolites
Antioxidants
Antiparasitic Agents
Antiprotozoal Agents
Antirheumatic Agents
Enzyme Inhibitors
Free Radical Scavengers
Gout Suppressants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
7 Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Harvard School of Public Health




Links to all studies - primarily for crawlers